Allstate reports Q1 2026 results on May 22 with analysts tilting constructively, even as options traders have quietly shifted to their most bullish posture in months.
The most striking signal heading into the print is in options. The put/call ratio has fallen to 1.07 — more than two standard deviations below its 20-day average of 1.21. That makes this the most call-heavy positioning in well over a year, sitting close to the 52-week low of 0.66 rather than the high of 1.34. The stock itself has been largely unmoved by this shift, trading just above $217 and up only about 2% on the week — a muted price response that makes the options skew more notable, not less.
The analyst community has been moving in one direction. Multiple firms raised targets in early May: Keefe, Bruyette & Woods lifted to $266 (maintaining Outperform), Piper Sandler moved to $268, and Wells Fargo edged to $243. The mean consensus target now sits at $241.50, implying roughly 11% upside from current levels. The bull case centres on personal auto recovery — policies-in-force growing 1.3% with momentum accelerating, backed by a meaningful earnings beat and favorable loss reserve releases. Bears push back on the combined ratio of 89.4%, which is materially worse than Allstate's long-run target of 95%, and point to competitive pricing pressure in personal lines that could compress margins as growth picks up. Barclays maintains its Underweight with a $208 target, the lone bearish holdout among recent movers.
Short interest tells a genuinely unexciting story here. At 2.7% of free float, it's low and has been drifting lower over the past week, down about 4%. Borrow is near-frictionless at 0.43%, and availability is exceptionally wide — shares available to borrow represent nearly 3,000% of current short interest, meaning there is no meaningful squeeze dynamic in the lending market. Factor scores reinforce the low-pressure picture: EPS momentum ranks in the 95th percentile over 30 days and the 86th percentile over 90 days, and the dividend score ranks 98th — supporting the idea that the positioning here is quality-driven accumulation rather than short-side pressure.
Operationally, Allstate delivered a 14.5% net income margin on $16.9 billion in trailing revenue, with return on equity running at 31.6%. The May 22 print will test whether the auto recovery is broadening fast enough — and whether the reserve releases that drove the last beat were a structural tailwind or a one-time cushion.
See the live data behind this article on ORTEX.
Open ALL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
